These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10203982)

  • 1. [The number of plasma exchanges in Guillain-Barré syndrome: evaluation by the removal rate of immunoglobulin G].
    Tagawa Y; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1998; 38(10-11):951-4. PubMed ID: 10203982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1997 Mar; 41(3):298-306. PubMed ID: 9066350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome.
    Ann Neurol; 1987 Dec; 22(6):753-61. PubMed ID: 2893583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of anti-glycolipid antibody-associated neuropathy].
    Yuki N
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1232-4. PubMed ID: 10791085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute relapsing Guillain-Barré syndrome after 5 and 7 years asymptomatic intervals].
    Kawada Y; Fujita N; Yuki N; Ohashi T; Ohnishi Y
    Rinsho Shinkeigaku; 1992 Feb; 32(2):187-90. PubMed ID: 1611778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1992 Jul; 32(1):94-7. PubMed ID: 1642477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal number of plasma exchanges needed to reduce immunoglobulin in Guillain-Barré syndrome.
    Yuki N; Tagawa Y; Hirata K
    Neurology; 1998 Sep; 51(3):875-7. PubMed ID: 9748046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG; Schmitz PI
    N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guillain-Barré syndrome in the adult: therapeutic aspects].
    Raphael JC; Cardinaud JP; Fourrier F; Guidet B; Perrotin D
    Schweiz Med Wochenschr; 1998 Sep; 128(39):1453-61. PubMed ID: 9793164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R; Barker J
    N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
    Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R
    Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Guillain-Barré syndrome by plasma exchange: proposal of a therapeutic strategy].
    Raphael JC; Chevret S; Jars-Guincestre MC; Chastang C; Gajdos P
    Rev Neurol (Paris); 1996 May; 152(5):359-64. PubMed ID: 8881430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome after bone marrow transplantation.
    Perry A; Mehta J; Iveson T; Treleaven J; Powles R
    Bone Marrow Transplant; 1994 Jul; 14(1):165-7. PubMed ID: 7951108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange in patients with Guillain-Barré syndrome: clinical improvement in patients with serum IgG antibodies to peripheral nerve tissue.
    Nyland H; Vedeler CA; Matre R; Halvorsen K; Fagius J; Osterman PO; Janzen RW; Skre H
    Int J Artif Organs; 1984 May; 7(3):133-6. PubMed ID: 6735503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional recovery in Guillain-Barre syndrome: benefits of plasma exchange].
    Cassuto-Viguier E; Sanderson F; Kullman B; Quaranta JF; Montagne N; Gueyraud A; Therre C; Duplay H
    Ann Med Interne (Paris); 1988; 139 Suppl 1():43-5. PubMed ID: 3247991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum demyelinating activity and Guillain-Barre syndrome: favorable effect of plasma exchange].
    Metral S; Raphael JC; Hort-Legrand CI; Elkharrat D
    Rev Neurol (Paris); 1989; 145(4):312-9. PubMed ID: 2660223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma exchange morbidity in Guillain-Barré syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group.
    Bouget J; Chevret S; Chastang C; Raphael JC
    Crit Care Med; 1993 May; 21(5):651-8. PubMed ID: 8482086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
    Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C
    Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.